Report Ocean’s latest analysis delves into the “Vietnam Viral Vector and Plasmid DNA Manufacturing Market” Report from 2024 to 2032, covering an array of market facets such as characteristics, size, ...

MeiraGTx (Nasdaq: MGTX) has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the Phase III development of AAV-GAD, a gene therapy for Parkinson’s disease.

Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...

Innovations Shaping the Future of Therapy Products Innovations in gene editing, vector development, and personalized medicine are distinctly shaping the future of therapy products within the cell and ...

Sarepta and Roche paused multiple Elevidys trials in the EU at the EMA’s request. HC Wainwright upgraded Sarepta to Neutral but sees Elevidys sales falling by Q2 2025. China’s new tariffs just ...

Credit: 4 PM production/Shutterstock. Atsena Therapeutics has completed an oversubscribed Series C financing round, raising $150m to support the advancement of its lead gene therapy programme, ...

Artis officially emerged from stealth on Wednesday, marking its launch as a San Diego-based cell and gene therapy CDMO with the acquisition of personalized medicine compatriot Landmark Bio.

Atsena Therapeutics has raised $150 million in an oversubscribed series C financing, with hopes that the funds can carry the biotech’s gene therapy designed to reverse or prevent blindness ...

1Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. *Corresponding Author: Laronna Colbert, Office of Clinical Evaluation, CBER, U.S. Food and ...

The death of a 16-year-old boy taking a gene therapy this month dealt a fresh blow to the Duchenne muscular dystrophy community. The patient died from acute liver failure months after starting ...

Its maker, Sarepta Therapeutics, hasn’t ruled out the possibility that the treatment, which uses an adeno-associated virus vector ... to adenovirus vectors, the first type used for gene therapy ...

“Not even a cold,” she adds. “For conditions like SMA, gene therapy works by delivering a functional copy of the faulty SMN1 gene into the body using a harmless virus. Once infused, the new gene ...